{"id":1012711,"date":"2026-10-22T11:26:21","date_gmt":"2026-10-22T15:26:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/"},"modified":"2026-10-22T11:26:21","modified_gmt":"2026-10-22T15:26:21","slug":"neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/","title":{"rendered":"NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight"},"content":{"rendered":"<div class=\"mw_release\">\n<p>DENVER, Oct.  22, 2026  (GLOBE NEWSWIRE) &#8212; (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bMSy9Wf5Vio-_c7uwJBRTRSbaxQPSxBowIVMMB0K3cxgGDfovPgNSIaarXi3S_lBGJN3gfq2csHjZnEC54lGiX2s8dThH6X_TN3abFcawAI=\" rel=\"nofollow\" target=\"_blank\"><u>247marketnews.com<\/u><\/a>) \u2014 NeOnc Technologies Holdings (NASDAQ: NTHI) is taking its brain cancer research story to a national television audience at a moment when several developments are putting the clinical-stage biotech in the spotlight. The company is scheduled to appear on <em>Health Uncensored with Dr. Drew<\/em> on Fox Business Network this Sunday, October 25, at 5:30 p.m. ET, following a series of milestones involving its investigational brain tumor therapies and growing presence in Abu Dhabi.<\/p>\n<p>CEO Amir F. Heshmatpour and founder and Chief Scientific Officer Thomas Chen, MD, PhD, will discuss NeOnc\u2019s approach to a persistent challenge in oncology: delivering potential treatments to tumors inside the brain while navigating the protective blood-brain barrier. The company\u2019s intranasal candidate, NEO100, is designed to provide a non-invasive route for delivering therapy to the brain without relying on surgery or systemic chemotherapy as the delivery method.<\/p>\n<p>The television appearance comes just days after NeOnc announced a memorandum of understanding with Abu Dhabi\u2019s Department of Health to explore collaboration in CNS cancer research, clinical development expertise, specialist training and real-world evidence. The framework also contemplates evaluating future clinical studies and the possibility of a regional presence.<\/p>\n<p>The company has also reported early clinical observations involving a critically ill three-year-old boy receiving investigational NEO100 through its Compassionate Care program in Abu Dhabi. His treating physicians reported that he was breathing independently without ventilator support and beginning to move his legs after treatment began.<\/p>\n<p>Together, the developments provide a compelling narrative: a biotech seeking to advance a different approach to brain tumor treatment, build international research relationships and bring its work to a wider audience. Heshmatpour summarized the ambition in the company\u2019s recent announcement: \u201cWe believe that we will make a significant impact in the standard of care for adults and kids suffering with brain cancer.\u201d<\/p>\n<p>NeOnc\u2019s Fox Business appearance arrives as its scientific mission gains visibility and its Abu Dhabi activities expand.<\/p>\n<p>\n        <strong>About 24\/7 Market News<\/strong>\n      <\/p>\n<p>In today&#8217;s fast-moving markets, visibility is everything and 24\/7 Market News (24\/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company\u2019s profile quickly and effectively. Whether you&#8217;re an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24\/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZTJh2PSKsxjTtaNCozXC3K4MuY2eqGUkrVk5oDvyw1mwQDjUXFHK6LpdiwFU9Bpn6qT12yPOY1btf6PsjJuzA73ZOCiLatpvcuzMoa7EMwk=\" rel=\"nofollow\" target=\"_blank\"><u>sales@247mnn.com<\/u><\/a> to discuss how 24\/7 can help accelerate your company\u2019s visibility and valuation trajectory.<\/p>\n<p>PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24\/7 is compensated by NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. For further disclosure information, please click <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=P4SOeJ6lfTP8jONJ8q4fYtSFcrlqH1DDx2-eMaI4m9_zb1mT29hjvWSbM3Gmha7fAcVDArg_h4yCrMyJ6nav-wUtEU07grfvl1JnOC9Qows=\" rel=\"nofollow\" target=\"_blank\"><u>here<\/u><\/a>. This should not be construed as financial or investment advice. Trading involves substantial risk; consult your financial advisor.<\/p>\n<p>Important Editorial Note: 247 highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication. Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>24\/7 Market News<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VsMjTZdusFNy0lGNMFCiGCH0SY2HYAVDO7jS8kj6YGeK4votu77j2d1CJ2w5YmmP4zy7Q-kA7Lwmf728eVUAl0USnGGacIVOAwzPMCAaXGM=\" rel=\"nofollow\" target=\"_blank\"><u>Editor@247mnn.com<\/u><\/a><\/p>\n<p>\n        <strong>Cautionary Note Regarding Forward-Looking Statements<\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company&#8217;s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; &#8220;estimates,&#8221; &#8220;aims,&#8221; &#8220;believes,&#8221; &#8220;hopes,&#8221; &#8220;potential&#8221; or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company&#8217;s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company&#8217;s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTI0MSM3OTEwNzgzIzUwMDE2MjE5NA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjQ2YWRmY2MtNTVkYi00YTlmLThmMGEtNWIyMGY4Zjk3NTUxLTUwMDE2MjE5NC0yMDI2LTEwLTIyLWVu\/tiny\/24-7-Market-News-and-NeOnc-Tec.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DENVER, Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; (247marketnews.com) \u2014 NeOnc Technologies Holdings (NASDAQ: NTHI) is taking its brain cancer research story to a national television audience at a moment when several developments are putting the clinical-stage biotech in the spotlight. The company is scheduled to appear on Health Uncensored with Dr. Drew on Fox Business Network this Sunday, October 25, at 5:30 p.m. ET, following a series of milestones involving its investigational brain tumor therapies and growing presence in Abu Dhabi. CEO Amir F. Heshmatpour and founder and Chief Scientific Officer Thomas Chen, MD, PhD, will discuss NeOnc\u2019s approach to a persistent challenge in oncology: delivering potential treatments to tumors inside the brain while navigating the protective blood-brain barrier. The &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1012711","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DENVER, Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; (247marketnews.com) \u2014 NeOnc Technologies Holdings (NASDAQ: NTHI) is taking its brain cancer research story to a national television audience at a moment when several developments are putting the clinical-stage biotech in the spotlight. The company is scheduled to appear on Health Uncensored with Dr. Drew on Fox Business Network this Sunday, October 25, at 5:30 p.m. ET, following a series of milestones involving its investigational brain tumor therapies and growing presence in Abu Dhabi. CEO Amir F. Heshmatpour and founder and Chief Scientific Officer Thomas Chen, MD, PhD, will discuss NeOnc\u2019s approach to a persistent challenge in oncology: delivering potential treatments to tumors inside the brain while navigating the protective blood-brain barrier. The &hellip; Continue reading &quot;NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-22T15:26:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTI0MSM3OTEwNzgzIzUwMDE2MjE5NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight\",\"datePublished\":\"2026-10-22T15:26:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/\"},\"wordCount\":730,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTI0MSM3OTEwNzgzIzUwMDE2MjE5NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/\",\"name\":\"NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTI0MSM3OTEwNzgzIzUwMDE2MjE5NA==\",\"datePublished\":\"2026-10-22T15:26:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTI0MSM3OTEwNzgzIzUwMDE2MjE5NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MTI0MSM3OTEwNzgzIzUwMDE2MjE5NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/","og_locale":"en_US","og_type":"article","og_title":"NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight - Market Newsdesk","og_description":"DENVER, Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; (247marketnews.com) \u2014 NeOnc Technologies Holdings (NASDAQ: NTHI) is taking its brain cancer research story to a national television audience at a moment when several developments are putting the clinical-stage biotech in the spotlight. The company is scheduled to appear on Health Uncensored with Dr. Drew on Fox Business Network this Sunday, October 25, at 5:30 p.m. ET, following a series of milestones involving its investigational brain tumor therapies and growing presence in Abu Dhabi. CEO Amir F. Heshmatpour and founder and Chief Scientific Officer Thomas Chen, MD, PhD, will discuss NeOnc\u2019s approach to a persistent challenge in oncology: delivering potential treatments to tumors inside the brain while navigating the protective blood-brain barrier. The &hellip; Continue reading \"NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-22T15:26:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTI0MSM3OTEwNzgzIzUwMDE2MjE5NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight","datePublished":"2026-10-22T15:26:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/"},"wordCount":730,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTI0MSM3OTEwNzgzIzUwMDE2MjE5NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/","name":"NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTI0MSM3OTEwNzgzIzUwMDE2MjE5NA==","datePublished":"2026-10-22T15:26:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTI0MSM3OTEwNzgzIzUwMDE2MjE5NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MTI0MSM3OTEwNzgzIzUwMDE2MjE5NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neonc-heads-to-fox-business-as-brain-cancer-milestones-put-its-mission-in-the-spotlight\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1012711"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012711\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1012711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1012711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1012711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}